Integrated PET/CT: current applications and future directions.
暂无分享,去创建一个
Thomas F Hany | G. V. von Schulthess | H. Steinert | T. Hany | Gustav K von Schulthess | Hans C Steinert
[1] Mithat Gonen,et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. , 2004, Radiology.
[2] M. Spieth,et al. A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] Tinsu Pan,et al. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] E. Nitzsche,et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. , 2001, Radiology.
[5] Richard L Wahl,et al. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] Thomas Beyer,et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Cyrill Burger,et al. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] P. Grigsby,et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone , 1992, Cancer.
[9] F. Fazio,et al. Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings. , 2004, Radiology.
[10] K. Geisinger,et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? , 2002, International journal of radiation oncology, biology, physics.
[11] Sasa Mutic,et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.
[12] F. Fazio,et al. Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment. , 2003, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[13] Ming-fang Wang,et al. Synthesis and evaluation of O-(3-[18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer. , 2003, Nuclear medicine and biology.
[14] A. Engel,et al. PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose for the evaluation of suspected infected vascular graft. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[15] Thomas Beyer,et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. , 2003, Radiology.
[16] T. Fleming,et al. Surgery for Recurrent Colon Cancer: Strategies for Identifying Resectable Recurrence and Success Rates after Resection , 1998, Annals of Internal Medicine.
[17] A. Figer,et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. , 2004, Radiology.
[18] E. Martin,et al. Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup. , 2001, Surgery.
[19] G. Jerusalem,et al. Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. , 2002, Clinical lymphoma.
[20] Thomas F Hany,et al. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. , 2002, Radiology.
[21] W. Oyen,et al. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] B. Bundy,et al. Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis--a Gynecologic Oncology Group study. , 1990, Gynecologic oncology.
[23] Y. Yonekura,et al. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] J Kotzerke,et al. Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] D. Tuveson,et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. , 2001, The New England journal of medicine.
[26] D. Visvikis,et al. CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[27] Paul Kinahan,et al. A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] N. Sadato,et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] D. Grisaru,et al. THE DIAGNOSTIC ACCURACY OF 18F-FLUORODEOXY-GLUCOSE PET/CT IN PATIENTS WITH GYNECOLOGICAL MALIGNANCIES , 2004, International Journal of Gynecologic Cancer.
[30] Sanjiv S. Gambhir,et al. Decision Analysis for the Cost-Effective Management of Recurrent Colorectal Cancer , 2001, Annals of surgery.
[31] H. Abdel-Nabi,et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. , 1998, Radiology.
[32] P. Schnyder,et al. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[33] H. Asamura,et al. Where is the boundary between N1 and N2 stations in lung cancer? , 2000, The Annals of thoracic surgery.
[34] Cyrill Burger,et al. Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] Paul Kinahan,et al. Attenuation correction for a combined 3D PET/CT scanner. , 1998, Medical physics.
[36] U. G. Dailey. Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.
[37] Claudio Landoni,et al. PET/CT and breast cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[38] J. Leonard,et al. Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma , 2002, Cancer.
[39] U. Metser,et al. PET-CT of extranodal lymphoma. , 2004, AJR. American journal of roentgenology.
[40] A. Alavi,et al. Investigation of thyroid, head, and neck cancers with PET. , 2004, Radiologic clinics of North America.
[41] P. Valk,et al. Cost-effectiveness of PET imaging in clinical oncology. , 1996, Nuclear medicine and biology.
[42] P. Dupont,et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] F. Fazio,et al. Diagnosis of local recurrence after radical prostatectomy , 2004, BJU international.
[44] M. Terris,et al. Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer , 2003, BJU international.
[45] P. Clavien,et al. Does the Novel PET/CT Imaging Modality Impact on the Treatment of Patients With Metastatic Colorectal Cancer of the Liver? , 2004, Annals of surgery.
[46] Cyrill Burger,et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. , 2003, International journal of radiation oncology, biology, physics.
[47] Cyrill Burger,et al. Respiration-induced attenuation artifact at PET/CT: technical considerations. , 2003, Radiology.
[48] Cyrill Burger,et al. Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion -- report of six cases. , 2002, Radiology.
[49] Valerie Treyer,et al. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[50] G. V. von Schulthess,et al. [The impact of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) on planning of radiotherapy]. , 2001, Terapevticheskii arkhiv.
[51] Ora Israel,et al. Cancer Recurrence: Diagnostic Value and Impact on Patient Management , 2004 .
[52] A. Buck,et al. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography , 1998, European Journal of Nuclear Medicine.
[53] T. Ravikumar,et al. Resection of hepatic metastases from colorectal cancer. Biologic perspective. , 1989, Annals of surgery.
[54] A. Lammertsma,et al. 18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non‐Hodgkin's lymphoma , 2003, British journal of haematology.
[55] Gerald Antoch,et al. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] J Kotzerke,et al. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. , 1997, Radiology.
[57] H. Fukuda,et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[58] G. V. von Schulthess,et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[59] R. Wahl,et al. PET-CT detection of abdominal recurrence of ovarian cancer: radiologic–surgical correlation , 2004, Abdominal Imaging.
[60] G. V. von Schulthess,et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. , 2005, Radiology.
[61] R. Hustinx,et al. The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[62] D. Grisaru,et al. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[63] A. Buck,et al. PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[64] M. Schäfer,et al. Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and Its Cost-Effectiveness , 2005, Annals of surgery.
[65] R. Wahl,et al. PET-CT: accuracy of PET and CT spatial registration of lung lesions , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[66] R. Wahl,et al. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[67] R Yancik,et al. Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. , 1993, Cancer.
[68] F Dehdashti,et al. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] Thomas F Hany,et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. , 2004, Radiology.
[70] Otakar Belohlavek,et al. Routine 18F-FDG PET Preoperative Staging of Colorectal Cancer: Comparison with Conventional Staging and Its Impact on Treatment Decision Making , 2003 .
[71] W. Oyen,et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[72] G. V. von Schulthess,et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.
[73] Cyrill Burger,et al. Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner , 2003, European Radiology.
[74] R. Wahl,et al. Direct Comparison of 18F-FDG PET and PET/CT in Patients with Colorectal Carcinoma , 2003 .
[75] G. Schulthess,et al. Clinical molecular anatomic imaging : PET, PET/CT, and SPECT/CT , 2003 .
[76] G. V. von Schulthess,et al. Detection of metallic implant-associated infections with FDG PET in patients with trauma: correlation with microbiologic results. , 2003, Radiology.
[77] E. Fishman,et al. Incremental value of CT in PET/CT of patients with colorectal carcinoma , 2004, Abdominal Imaging.
[78] C. Meltzer,et al. Teflon-induced granuloma: a false-positive finding with PET resolved with combined PET and CT. , 2003, AJNR. American journal of neuroradiology.
[79] O. Belohlávek,et al. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[80] C. Van de Wiele,et al. Fluorine-18 Fluorodeoxyglucose-Positron Emission Tomography: A Highly Accurate Imaging Modality for the Diagnosis of Chronic Musculoskeletal Infections , 2001 .
[81] Thomas F Hany,et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? , 2004, Radiology.
[82] U. Buell,et al. Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT? , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[83] Y Yonekura,et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.